tiprankstipranks
Curis Provides First Quarter 2024 Business Update
PremiumPress ReleasesCuris Provides First Quarter 2024 Business Update
2M ago
Curis reports Q1 EPS ($2.05), consensus ($2.12)
PremiumThe Fly
Curis reports Q1 EPS ($2.05), consensus ($2.12)
2M ago
Two new option listings and  option delistings on March 25th
PremiumThe Fly
Two new option listings and option delistings on March 25th
4M ago
Curis price target lowered to $26 from $51 at H.C. Wainwright
PremiumThe FlyCuris price target lowered to $26 from $51 at H.C. Wainwright
5M ago
Curis files $300M common stock offering
PremiumThe Fly
Curis files $300M common stock offering
5M ago
Curis sees cash, cash equivalents and investments sufficient into 2025
PremiumThe Fly
Curis sees cash, cash equivalents and investments sufficient into 2025
5M ago
Cantor Fitzgerald healthcare analysts hold an analyst/industry conference call
PremiumThe FlyCantor Fitzgerald healthcare analysts hold an analyst/industry conference call
7M ago
Curis’ licensed emavusertib shows efficacy in lymphoma trial
PremiumThe Fly
Curis’ licensed emavusertib shows efficacy in lymphoma trial
7M ago
Curis presented data from the TakeAim Leukemia study at 2023 ASH conference
PremiumThe Fly
Curis presented data from the TakeAim Leukemia study at 2023 ASH conference
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100